|
|
|
Insider
Information: |
Luo Mary Z. |
Relationship: |
COO,Chief Scientist & ... |
City: |
Rancho Cucamonga |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
2,433,554 |
|
Indirect Shares
|
8,057,435 |
|
|
Direct
Value |
$102,574,301 |
|
|
Indirect Value
|
$339,620,885 |
|
|
Total
Shares |
10,490,989 |
|
|
Total
Value |
$442,195,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-12 |
4/A |
OE |
$12.97 |
$547,632 |
I/I |
42,223 |
718,221 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-12 |
4 |
OE |
$12.97 |
$1,079,791 |
D/D |
83,253 |
994,889 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-12 |
4/A |
OE |
$12.97 |
$1,079,791 |
D/D |
83,253 |
1,007,894 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO and Chief Scientist |
|
2015-06-15 |
4 |
OE |
$12.97 |
$649,291 |
D/D |
50,061 |
961,697 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO and Chief Scientist |
|
2015-06-15 |
4 |
D |
$16.29 |
$76,239 |
D/D |
(4,679) |
911,636 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO and Chief Scientist |
|
2015-06-15 |
4 |
AS |
$16.29 |
$739,445 |
D/D |
(45,382) |
916,315 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO and Chief Scientist |
|
2015-08-17 |
4 |
OE |
$12.97 |
$109,999 |
I/I |
8,481 |
670,147 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO and Chief Scientist |
|
2015-08-17 |
4 |
OE |
$12.97 |
$109,999 |
D/D |
8,481 |
920,117 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Science Officer |
|
2015-12-01 |
4 |
AS |
$15.49 |
$309,780 |
I/I |
(20,000) |
7,611,594 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Science Officer |
|
2015-12-03 |
4 |
AS |
$15.42 |
$286,461 |
I/I |
(18,583) |
7,593,011 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-04 |
4 |
AS |
$14.95 |
$429,302 |
I/I |
(28,712) |
7,564,299 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-07 |
4 |
AS |
$14.59 |
$219,490 |
I/I |
(15,046) |
7,549,253 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-08 |
4 |
AS |
$14.50 |
$353,118 |
I/I |
(24,359) |
7,524,894 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-09 |
4 |
AS |
$14.29 |
$376,133 |
I/I |
(26,319) |
7,498,575 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-10 |
4 |
AS |
$14.32 |
$313,884 |
I/I |
(21,915) |
7,476,660 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-11 |
4 |
AS |
$14.05 |
$211,736 |
I/I |
(15,066) |
7,461,594 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
79,435 |
767,666 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
184,466 |
1,129,902 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-26 |
4 |
D |
$11.96 |
$187,904 |
D/D |
(15,711) |
1,114,191 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-26 |
4 |
D |
$11.96 |
$80,180 |
I/I |
(6,704) |
760,962 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-27 |
4 |
D |
$11.96 |
$103,346 |
I/I |
(8,641) |
752,321 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-27 |
4 |
D |
$11.96 |
$309,238 |
D/D |
(25,856) |
1,088,335 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2016-09-20 |
4 |
AS |
$20.73 |
$4,376,738 |
D/D |
(207,350) |
1,088,335 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2016-09-20 |
4 |
OE |
$16.75 |
$3,473,735 |
D/D |
207,350 |
1,295,685 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2016-09-20 |
4 |
AS |
$20.74 |
$3,825,732 |
I/I |
(181,768) |
752,321 |
0 |
- |
|
170 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|